Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | +5.44% | +4.49% | -19.21% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 37.62 | 21.66 | 35.59 | 18.99 | 226.4 | 182.7 | - | - |
Enterprise Value (EV) 1 | 37.62 | 21.66 | 35.59 | 18.99 | 226.4 | 182.7 | 182.7 | 182.7 |
P/E ratio | -3.46 x | -4.06 x | -7.77 x | -1.05 x | -5.47 x | -349 x | 17 x | 7.51 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 0.7 x | 0.43 x | 0.6 x | 0.35 x | 2.8 x | 1.76 x | 1.54 x | 1.35 x |
EV / Revenue | 0.7 x | 0.43 x | 0.6 x | 0.35 x | 2.8 x | 1.76 x | 1.54 x | 1.35 x |
EV / EBITDA | 1,792 x | 6.2 x | - | - | 26 x | 8.64 x | 5.5 x | 3.87 x |
EV / FCF | - | - | - | - | - | 5.65 x | 4.95 x | 3.48 x |
FCF Yield | - | - | - | - | - | 17.7% | 20.2% | 28.7% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 4,963 | 5,132 | 6,938 | 7,008 | 52,417 | 52,354 | - | - |
Reference price 2 | 7.580 | 4.220 | 5.130 | 2.710 | 4.320 | 3.490 | 3.490 | 3.490 |
Announcement Date | 2/26/20 | 2/24/21 | 2/24/22 | 3/31/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 53.94 | 50.82 | 59.03 | 54.13 | 80.75 | 103.9 | 118.8 | 135.6 |
EBITDA 1 | 0.021 | 3.493 | - | - | 8.711 | 21.16 | 33.25 | 47.21 |
EBIT 1 | -5.274 | -0.501 | -0.201 | -11.64 | -1.932 | 8.038 | 20.01 | 34.6 |
Operating Margin | -9.78% | -0.99% | -0.34% | -21.5% | -2.39% | 7.74% | 16.84% | 25.51% |
Earnings before Tax (EBT) 1 | -10.23 | -5.407 | -3.934 | -18.08 | -20.05 | -0.4787 | 11.18 | 25.83 |
Net income 1 | -10.44 | -5.339 | -4.372 | -18.11 | -21.39 | -0.4787 | 11.18 | 25.83 |
Net margin | -19.36% | -10.51% | -7.41% | -33.45% | -26.49% | -0.46% | 9.42% | 19.04% |
EPS 2 | -2.190 | -1.040 | -0.6600 | -2.590 | -0.7900 | -0.0100 | 0.2050 | 0.4650 |
Free Cash Flow 1 | - | - | - | - | - | 32.34 | 36.92 | 52.46 |
FCF margin | - | - | - | - | - | 31.13% | 31.08% | 38.68% |
FCF Conversion (EBITDA) | - | - | - | - | - | 152.88% | 111.04% | 111.14% |
FCF Conversion (Net income) | - | - | - | - | - | - | 330.08% | 203.12% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/26/20 | 2/24/21 | 2/24/22 | 3/31/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 12.15 | 13.96 | 11.9 | 14.6 | 13.6 | 14.03 | 13.55 | 17.54 | 23.36 | 26.31 | 22.25 | 25.18 | 26.94 | 29.42 | 25.8 |
EBITDA 1 | - | - | - | - | - | - | -2.395 | 0.874 | 5.418 | 5.03 | 2.006 | 4.448 | 5.924 | 8.828 | 3.6 |
EBIT 1 | -2.022 | -2.752 | -4.147 | -1.974 | -3.411 | -2.108 | -3.302 | -1.208 | 1.854 | 0.724 | -0.9683 | 1.215 | 2.521 | 5.304 | 0.5 |
Operating Margin | -16.64% | -19.71% | -34.85% | -13.52% | -25.08% | -15.03% | -24.38% | -6.89% | 7.94% | 2.75% | -4.35% | 4.83% | 9.36% | 18.03% | 1.94% |
Earnings before Tax (EBT) 1 | -4.352 | -4.139 | -5.955 | -3.098 | -5.245 | -3.781 | -4.968 | -10 | -1.301 | -3.774 | -3.114 | -0.9307 | 0.3747 | 3.158 | -1.8 |
Net income 1 | -4.183 | -4.106 | -5.955 | -3.115 | -5.257 | -3.78 | -4.982 | -10.7 | -1.93 | -3.781 | -3.114 | -0.9307 | 0.3747 | 3.158 | -1.8 |
Net margin | -34.42% | -29.41% | -50.05% | -21.33% | -38.66% | -26.94% | -36.78% | -61% | -8.26% | -14.37% | -14% | -3.7% | 1.39% | 10.74% | -6.98% |
EPS 2 | -0.6000 | -0.5900 | -0.8500 | -0.4500 | -0.7500 | -0.5400 | -0.7100 | -1.320 | -0.0600 | -0.0700 | -0.0567 | -0.0133 | 0.006670 | 0.0567 | -0.0300 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 10/28/21 | 2/24/22 | 5/9/22 | 7/27/22 | 11/14/22 | 3/31/23 | 5/15/23 | 8/10/23 | 10/26/23 | 3/7/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | - | - | 32.3 | 36.9 | 52.5 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | - | - | - | 0.3 | 0.32 | 0.33 |
Capex / Sales | - | - | - | - | - | 0.29% | 0.27% | 0.24% |
Announcement Date | 2/26/20 | 2/24/21 | 2/24/22 | 3/31/23 | 3/7/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.21% | 183M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ALIM Stock
- Financials Alimera Sciences, Inc.